NCT00908999 Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Status COMPLETED Phase N/A
NCT00905372 Effect of LY2062430 on the Progression of Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00904683 Effect of LY2062430 on the Progression of Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00901498 Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00890890 A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00888056 Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT00886951 Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease Status TERMINATED Phase PHASE1
NCT00884507 A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00880451 Development and Decline of Brain and Cognition Through the Life Span Status COMPLETED Phase N/A
NCT00880412 A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00880347 Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia Status COMPLETED Phase NA
NCT00876863 Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00874939 A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) Status TERMINATED Phase PHASE1
NCT00870519 Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects Status TERMINATED Phase PHASE1